Guided Therapeutics, Inc. (OTCBB:GTHP) have seen a year over year change of sales growth of -0.37637. The 782 market value company based out of United States of America is an important player in the Health Care Equipment & Services sector.
While sales growth can be a key driver for a company’s stock performance, there are many other factors to consider as well. Here we’ll take a look at several other notable indicators.
Guided Therapeutics, Inc. (OTCBB:GTHP) closed the recent session at 0.003700 with a market value of $782.
Keeping watch on technicals may involve many different plans and scenarios. Investors may be seeking to get some clarity about a certain stock’s history, and eventually try to project the future. With so much historical data available, investors may choose to look at many different time frames when examining a stock. Going back days, months, of even years, may help broaden the scope and help investors see the bigger picture. When companies gear up to release the next round of quarterly earnings results, investors will be closely watching to see how profitable the overall quarter was. Occasionally, low expectations may provide ample impetus for future stock gains. Per usual, there will most likely be big winners and losers depending on the strength of the individual reports.
Turning to some key growth data as decimals. One year cash flow growth ratio is calculated on a trailing 12 months basis and is a one year percentage growth of a firm’s cash flow from operations. This number stands at -0.09729 for Guided Therapeutics, Inc. (OTCBB:GTHP). The one year Growth EBIT ratio stands at -0.06898 and is a calculation of one year growth in earnings before interest and taxes. The one year EBITDA growth number holds at 0.36501 which is calculated similarly to EBIT Growth with just the addition of amortization.
Taking even a further look we note that the 1 year Free Cash Flow (FCF) Growth is at -0.09729. The one year growth in Net Profit after Tax is 1.00391 and lastly sales growth was -0.37637.
Guided Therapeutics, Inc. (OTCBB:GTHP) has a current suggested portfolio ownership target rate of 0.00420 (as a decimal) ownership. Target weight is the volatility adjusted recommended position size for a stock in your portfolio. The maximum target weight is 7% for any given stock. The indicator is based off of the 100 day volatility reading and calculates a target weight accordingly. The more recent volatility of a stock, the lower the target weight will be. The 3-month volatility stands at 186.062100 (decimal), the 6-month at 236.921000 and the 12-month at 151.147600. This is the normal returns and standard deviation of the stock price over three months annualized.
Taking look at some key returns and margins data we can note the following: Guided Therapeutics, Inc. (OTCBB:GTHP) has Return on Invested Capital (ROIC) of -48.901639, with a 5-year average of -4.820629 and an ROIC quality score of -0.210599. Why is ROIC important? It’s one of the most fundamental metrics in determining the value of a given stock. It helps potential investors determine if the firm is using it’s invested capital to return profits.
Changing lanes and looking at some Debt ratios, Guided Therapeutics, Inc. (OTCBB:GTHP) has a debt to equity ratio of -0.25728 and a Free Cash Flow to Debt ratio of -0.232922. This ratio provides insight as to how high the firm’s total debt is compared to its free cash flow generated. In terms of Net Debt to EBIT, that ratio stands at -1.60375. This ratio reveals how easily a company is able to pay interest and capital on its net outstanding debt. The lower the ratio the better as that indicates that the company is able to meet its interest and capital payments. Lastly we’ll take note of the Net Debt to Market Value ratio. Guided Therapeutics, Inc.’s ND to MV current stands at 6.119369. This ratio is calculated as follows: Net debt (Total debt minus Cash ) / Market value of the company.
Investors may be employing many various trading strategies when approaching the markets. Investors may be hoping for sustained upward trends where stocks calmly and steadily advance in that direction. Of course, this isn’t typically the case. Having some foreign exposure in the portfolio may provide overall diversification and also potentially boost performance over time. Investing globally may entail considering the risks of investing in economies that are inherently less developed and thus less liquid. A diversified approach may target foreign markets that have solid growth potential and favorable domestic conditions, such as a stable political setting. Investing globally may require much more research and dedication in order to fully understand the ins and outs.
